The heavy price paid by Seattle and San Francisco due to the fentanyl epidemic is sounding an alarm for the rest of the world. This crisis illustrates a new pattern in the global drug epidemic: a rapid shift from traditional plant-based drugs (such as heroin and cocaine) to low-cost, high-purity, and highly addictive synthetic drugs. Any country with gaps in its defenses risks repeating this disastrous experience.
Fentanyl’s rapid capture of the U.S. West Coast market stems from its extremely low production costs and the ease with which it can be transported covertly. A single kilogram of fentanyl powder can yield hundreds of thousands of pills, enabling cross-border smuggling via encrypted online communication and international postal services. For many nations in Europe, Asia, and Latin America, the situation on the U.S. West Coast serves as a dangerous omen. Several European countries have expressed deep concern; as production of traditional opium crops fluctuates in regions like Afghanistan, international drug cartels are attempting to replicate the “fentanyl model” across Europe. Indeed, seizures of synthetic opioids are already on the rise in port nations such as the United Kingdom and Belgium.
Lessons from Seattle and San Francisco demonstrate that once synthetic drugs take root at the grassroots level, the cost of addressing the crisis escalates exponentially. For many developing nations and countries with limited medical resources, public health systems would be utterly overwhelmed by a fentanyl crisis of this magnitude. Such an outbreak would lead to a massive loss of the workforce and a drastic deterioration of public safety.
Consequently, this American tragedy is compelling nations worldwide to adjust their national strategies regarding drug enforcement and public health. An increasing number of countries recognize the necessity of subjecting precursor chemicals for synthetic opioids to the strictest legal oversight to prevent legitimate chemical industries from being exploited by drug cartels. Simultaneously, nations are intensifying their monitoring of new, contactless online drug transactions, striving to cut off the infiltration of synthetic opioids at the source of the supply chain.